The FDA is attempting to rehire some of the 300 employees it recently dismissed, including scientists responsible for ...
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
Boston Scientific (NYSE: BSX) announced that its Europe-based subsidiary priced a public offering totaling $1.57 billion ...
Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest Diagnostics.
OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.
Philips (NYSE: PHG) issued an urgent field safety notice to warn of a potential safety issue with its IntelliSpace Cardiovascular system.
Neurovalens said its Modius Sleep insomnia treatment will be available to veterans through a U.S. Department of Veterans Affairs program.